163 related articles for article (PubMed ID: 37309115)
1. Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events.
Noh Y; Ko HY; Kim JH; Yoon D; Choe YJ; Choe SA; Jung J; Shin JY
Epidemiol Health; 2023; 45():e2023054. PubMed ID: 37309115
[TBL] [Abstract][Full Text] [Related]
2. Active Safety Surveillance of Four Types of COVID-19 Vaccines: A National Study from Jordan.
Abdel-Qader DH; Abdel-Qader H; Silverthorne J; Kongkaew C; Al Meslamani AZ; Hayajneh W; Ata OMA; Shnaigat W; AbuRuz S; Al Nsour M; Alhariri A; Shnewer K; Da'ssan M; Obeidat NM; Nusair KE; Jalamdeh MS; Hawari F; Khader K; Hakim T; Hammad FA; Al Qudah M; Asad M
Clin Drug Investig; 2022 Oct; 42(10):813-827. PubMed ID: 35999428
[TBL] [Abstract][Full Text] [Related]
3. Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands.
Kant A; Jansen J; van Balveren L; van Hunsel F
Drug Saf; 2022 Apr; 45(4):319-331. PubMed ID: 35314943
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says.
Chen G; Li X; Sun M; Zhou Y; Yin M; Zhao B; Li X
Front Immunol; 2021; 12():669010. PubMed ID: 34093567
[TBL] [Abstract][Full Text] [Related]
5. [Adverse events following immunization reported with COVID-19 vaccines in Burkina Faso: Analysis of spontaneous reports].
Sawadogo R; Ouoba J; Ilboudo D; Tchoumbi E; Lankoandé-Haro S; Fofana S; Sombié I; Samadoulougou S; Kirakoya-Samadoulougou F
Sante Publique; 2024 Feb; 35(6):149-159. PubMed ID: 38388395
[TBL] [Abstract][Full Text] [Related]
6. Willingness to receive a vaccine is influenced by adverse events following immunisation experienced by others.
Christou-Ergos M; Wiley KE; Leask J
Vaccine; 2023 Jan; 41(1):246-250. PubMed ID: 36446655
[TBL] [Abstract][Full Text] [Related]
7. Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System.
Jeon M; Kim J; Oh CE; Lee JY
J Korean Med Sci; 2021 May; 36(17):e114. PubMed ID: 33942578
[TBL] [Abstract][Full Text] [Related]
8. A Prospective Observational Study on BBV152 Coronavirus Vaccine Use in Adolescents and Comparison with Adults: Interim Results of the First Real-World Safety Analysis.
Kaur U; K L A; Chauhan M; Joshi A; Das A; Kansal S; Jaisawal V; Patwardhan K; Chakrabarti SS
Drug Saf; 2022 Oct; 45(10):1099-1109. PubMed ID: 36030299
[TBL] [Abstract][Full Text] [Related]
9. Otorhinolaryngologic complications after COVID-19 vaccination, vaccine adverse event reporting system (VAERS).
Shin J; Shim SR; Lee J; Ryu HS; Kim JY
Front Public Health; 2023; 11():1338862. PubMed ID: 38269374
[TBL] [Abstract][Full Text] [Related]
10. Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom.
Otero-Losada M; Petrovsky N; Alami A; Crispo JA; Mattison D; Capani F; Goetz C; Krewski D; Perez-Lloret S
Expert Opin Drug Saf; 2023 Apr; 22(4):343-349. PubMed ID: 36043937
[TBL] [Abstract][Full Text] [Related]
11. The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.
Deng L; Glover C; Dymock M; Pillsbury A; Marsh JA; Quinn HE; Leeb A; Cashman P; Snelling TL; Wood N; Macartney K
Med J Aust; 2022 Aug; 217(4):195-202. PubMed ID: 35781813
[TBL] [Abstract][Full Text] [Related]
12. Updates on Vaccine Safety and Post-Licensure Surveillance for Adverse Events Following Immunization in South Korea, 2005-2017.
Yoon D; Kim JH; Lee H; Shin JY
Yonsei Med J; 2020 Jul; 61(7):623-630. PubMed ID: 32608206
[TBL] [Abstract][Full Text] [Related]
13. Adverse events following immunization associated with coronavirus disease 2019 (COVID-19) vaccines: A descriptive analysis from VigiAccess.
Yamoah P; Mensah KB; Attakorah J; Padayachee N; Oosthuizen F; Bangalee V
Hum Vaccin Immunother; 2022 Nov; 18(6):2109365. PubMed ID: 35947052
[TBL] [Abstract][Full Text] [Related]
14. Reporting adverse events of ChAdOx1 nCoV-19 coronavirus vaccine (Recombinant) among the vaccinated healthcare professionals: A cross-sectional survey.
Kaur S; Singh A; Saini S; Rohilla L; Kaur J; Chandi A; Kaur G; Singh M; Kumar P; Soni SL; Kajal K; Naik NB; Malhotra P; Verma S; Gupta M; Devnani M; Das K; Pandav SS; Puri GD
Indian J Med Res; 2022 Jan; 155(1):123-128. PubMed ID: 35859438
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study.
Ferrara F; Mancaniello C; Varriale A; Sorrentino S; Zovi A; Nava E; Trama U; Boccellino M; Vitiello A
Clin Drug Investig; 2022 Dec; 42(12):1065-1074. PubMed ID: 36274082
[TBL] [Abstract][Full Text] [Related]
16. Spontaneously reported adverse events following COVID-19 basic and booster immunizations in the Netherlands.
van der Boor SC; Schmitz-de Vries ETJ; Smits D; Scholl JHG; Rolfes L; van Hunsel F
Vaccine; 2023 Jun; 41(29):4319-4326. PubMed ID: 37286408
[TBL] [Abstract][Full Text] [Related]
17. Serious adverse event following immunization and thromboembolic events associated with COVID19 vaccination: An analysis of nationwide causality assessment from India.
Gandhi AP; Venkatesh U; Murali N
Indian Heart J; 2023; 75(2):139-144. PubMed ID: 36863611
[TBL] [Abstract][Full Text] [Related]
18. Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance.
Ruggiero R; Balzano N; Di Napoli R; Mascolo A; Berrino PM; Rafaniello C; Sportiello L; Rossi F; Capuano A
Front Immunol; 2022; 13():956825. PubMed ID: 36177033
[TBL] [Abstract][Full Text] [Related]
19. Post COVID-19 vaccination: AusVaxSafety survey participation and adverse events - a community-based regional Queensland study.
Hamilton E; Oversby S; Kitchener S; Ratsch A
Aust N Z J Public Health; 2022 Dec; 46(6):738-744. PubMed ID: 36190203
[TBL] [Abstract][Full Text] [Related]
20. Safety of COVID-19 vaccines in pregnancy: a VAERS based analysis.
Santi Laurini G; Montanaro N; Motola D
Eur J Clin Pharmacol; 2023 May; 79(5):657-661. PubMed ID: 36961579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
